Background: Twenty to thirty percent of persons with Trypanosoma cruzi infection eventually develop cardiomyopathy. If an early indicator were to be identified and validated in longitudinal studies, this could enable ...

Objetivo. Identificar la prevalencia del autoinforme de síntomas, del acceso al testeo y del diagnóstico de la enfermedad por el coronavirus del 2019 (COVID-19, por su sigla en inglés), así como su asociación con determinantes ...

Morbidity and mortality from Chagas cardiomyopathy have declined over the last three decades because of disruption of domestic vector-borne transmission, improved Trypanosoma cruzi infection treatment programs, and increasing ...